Venetoclax combined chemotherapy versus chemotherapy alone for acute myeloid leukemia: a systematic review and meta-analysis

Venetoclax combined chemotherapy versus chemotherapy alone for acute myeloid leukemia: a systematic review and meta-analysis

ObjectiveTo compare the efficacy and safety of venetoclax (VEN) in combination with chemotherapy (chemo) versus chemo alone in the treatment of acute myeloid leukemia (AML).MethodTo compare the efficacy and/or safety of VEN+chemo versus chemotherapy alone for AML, PubMed, Embase, Web of Science, and...

Full description

Bibliographic Details
Main Authors: Jingkui Zhu, Jixin Fan, Tiantian Xie, Haiqiu Zhao, Runqing Lu, Yinyin Zhang, Yingmei Li, Xinsheng Xie, Dingming Wan, Zhongxing Jiang, Fei He, Rong Guo
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-03-01
Series:Frontiers in Oncology
Subjects:
meta-analysis
acute myeloid leukemia
venetoclax
chemotherapy, efficacy
adverse events
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1361988/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2024.1361988/full

Similar Items